Category: Health Law Highlights

Categories
Health Law Highlights

How Chief AI Officers Are Guiding Healthcare Companies Into The Future

Summary of article from Forbes, by Andrei Kasyanau:

Artificial intelligence (AI) is transforming healthcare, necessitating the role of a Chief AI Officer (CAIO) to guide AI strategy and implementation, foster AI innovation, ensure ethical AI use, and build AI talent and partnerships. The CAIO is pivotal in identifying high-value AI opportunities, driving AI adoption, and overseeing the ethical deployment of AI systems. They also play a crucial part in building a strong AI talent pipeline and fostering strategic partnerships. Real-life cases from Mayo Clinic, GE Healthcare, and Elevance Health demonstrate the positive impact of a CAIO in healthcare organizations. The need for a CAIO becomes apparent when organizations face multiple AI initiatives, challenges in scaling AI solutions, concerns about AI ethics, and a need for dedicated AI talent and partnerships.

Categories
Health Law Highlights

Four Ways Price Transparency Will Transform Healthcare

Summary of article from D Magazine, by Dr. Eric Bricker:

The lack of healthcare price transparency presents a significant challenge, particularly for insured individuals with high out-of-pocket costs. The federal government has mandated hospitals to disclose prices, but compliance remains low. Some health insurance companies are now linking out-of-pocket costs with healthcare providers’ price and quality, incentivizing patients to opt for high-value care. Price transparency will enable fair treatment of payers, encourage competition among providers, and could potentially reduce healthcare costs. Improved transparency is also expected to enhance the quality of care, countering the current system that often incentivizes lower quality.

Categories
Health Law Highlights

Enhancing the Humanity in Health Care With AI

Summary of podcast from Deloitte Insights:

The World Health Organization predicts a shortage of 10 million healthcare workers by 2030, which could result in increased wait times, decreased health outcomes, and worker burnout. AI has the potential to alleviate these issues by automating administrative tasks, thereby freeing up clinicians’ time and making healthcare more human-centric. However, the adoption of AI in healthcare is slowed by apprehensions about the technology and concerns about data privacy. The successful implementation of AI in healthcare requires clinician adoption and leadership, and solutions must be designed to integrate seamlessly into existing workflows. Ultimately, AI has the potential to transform healthcare delivery, improve efficiency, and enhance patient care, but this requires a collaborative approach, robust data governance, and a focus on enhancing rather than replacing human roles.

Categories
Health Law Highlights

Navigating the National Practitioner Data Bank: A Guide for Healthcare Professionals

Summary of article from Ward and Smith, P.A., by Amy G. Fitzhugh, James A. Wilson:

The National Practitioner Data Bank (NPDB) is a repository of reports on actions taken against healthcare practitioners, providers, and suppliers, aiming to prevent practitioners from moving locations without disclosing adverse events. Entities such as hospitals, health plans, and state licensing boards submit reports to the NPDB, which include Adverse Action Reports, Medical Malpractice Payment Reports, and Judgment or Conviction Reports. The NPDB, analogous to credit reports, contains information that could negatively impact a healthcare professional’s credentialing decision, and like a credit report, it is not publicly accessible but available to authorized users. To manage their NPDB profile, healthcare professionals should occasionally self-query their records, add their own side of the story if something is reported, and dispute inaccuracies with the reporting entity. If the reporting entity denies a correction, the NPDB has a process to dispute a report and, if in agreement, can request the reporting entity to correct or void the report.

Categories
Health Law Highlights

With AI, Keep Patient Satisfaction Top of Mind, Says Health IT Investor

Summary of article from Healthcare IT News, by Bill Siwicki:

Artificial intelligence (AI) is poised to revolutionize healthcare, with investors viewing it with cautious optimism due to its potential for significant advancements and the need for careful consideration of secondary implications. AI can catalyze the shift towards value-based care by improving patient outcome measurement, personalizing treatments, and predicting health issues for early intervention. AI can also streamline the revenue cycle management process by automating tasks, predicting revenue leakage, and enhancing billing accuracy. While AI won’t replace clinicians, it will assist in decision-making by analyzing complex data points, providing evidence-based recommendations, and identifying potential drug interactions. Despite challenges like data privacy and integration into existing systems, AI’s development trajectory in healthcare is promising.

Categories
Health Law Highlights

A Pair of Texas-Based Schools Are on the Leading Edge of Teaching Doctors About AI

Summary of article from Health Leaders, by Christopher Cheney:

The University of Texas Health Science Center at San Antonio and University College at the University of Texas at San Antonio are the first institutions to offer an MD/MS dual degree in artificial intelligence, recognizing the growing importance of AI in healthcare. The program, which began planning in 2018 and launched in 2022, offers three pathways: computer science, data analytics, and robotics, with most students choosing data analytics. The MS in AI degree focuses on implementing AI tools such as machine learning, neural networks, and natural language processing. This education is expected to improve diagnostic accuracy, personalize treatment plans, streamline operations, and contribute to medical research. The program aims to position physicians in leadership roles in AI technology development, ensuring it is patient-centered and not solely profit-driven.

Categories
Health Law Highlights

US Sues Telehealth Companies Over Data Sharing, Cancelation Policies

Summary of article from mHealth Intelligence, by Anuja Vaidya:

The US Department of Justice (DOJ) and the Federal Trade Commission (FTC) have filed an amended complaint against telehealth companies, including Cerebral Inc., Zealthy Inc., Gronk Inc., and Bruno Health P.A., alleging misuse of patients’ personal health data, deceptive cancellation practices, and unauthorized disclosure of sensitive data. The complaint also accuses the companies of deploying online tracking technologies for targeted advertisements without user consent. The government alleges that the companies violated the Federal Trade Commission Act (FTC Act), the Opioid Addiction Recovery Fraud Prevention Act of 2018, and the Restore Online Shoppers’ Confidence Act (ROSCA). While the claims against Cerebral have been settled, with the company agreeing to pay $5 million in consumer redress and a $2 million civil penalty, the government continues to pursue claims against the other companies and individuals involved. Cerebral has also been scrutinized for its controlled substance prescriptions and alleged “unlawful business practices”.

Categories
Health Law Highlights

New Part II Rules

Summary of article from Gordon Feinblatt LLC, by Alexandria K. Monanio:

The Confidentiality of Substance Use Disorder (SUD) Patient Records regulations, known as Part II, have been updated to better align with HIPAA privacy protections. Providers have until April 2026 to comply with these changes, which include allowing patients to sign a single consent for all future uses of treatment, payment, and health care operations data. However, identifiable Part II data cannot be disclosed in legal proceedings without explicit patient consent or a court order. The updated rules also provide a safe harbor for investigative agencies and allow patients to file Part II violation complaints directly to the Secretary of HHS. The HHS plans to develop guidance and conduct outreach to facilitate compliance with the new rule, with additional changes to the HIPAA rules expected in the future.

Categories
Health Law Highlights

Texas Children’s Hospital Whistleblower Doctor Indicted on Four Counts of Criminal HIPAA Violations

Summary of article from The HIPAA Journal, by Steve Adler:

Dr. Eithan Haim, a surgeon from Texas Children’s Hospital, has been indicted on four counts of violating the Health Insurance Portability and Accountability Act (HIPAA) by the Department of Justice. Dr. Haim allegedly leaked documents proving the hospital continued to provide gender-affirming care to minors, despite public claims to the contrary, following legal threats from Texas Governor Greg Abbott. The leaked documents, shared with reporter Christopher F. Rulo, indicated that treatments, including hormone-related therapies and implanted puberty blockers, were provided throughout 2022 and 2023. Dr. Haim, who admitted to being the whistleblower, is now facing prosecution, though he maintains that all sensitive patient information was redacted from the documents. This case follows a new law passed by the Texas Legislature banning gender-affirming interventions, which Texas Children’s Hospital has since complied with.

Categories
Health Law Highlights

Checking the Pulse: An Approach to Telehealth Privacy and Cybersecurity Due Diligence

Summary of article from Troutman Pepper, by Brent Hoard, Emma Trivax, Erin Whaley:

The rapid expansion of telehealth introduces complex privacy and cybersecurity challenges, impacting financing or acquisition decisions in the health care sector. A strategic pre-diligence review is advised to identify potential risks and regulatory environment, including HIPAA, FTC’s Health Breach Notification Rule, state-specific privacy laws, and international privacy laws. The pre-diligence review should also include an examination of the target’s privacy policy, website, and data practices. This information should then inform a comprehensive due diligence process, including the development of a request list and a framework for organizing diligence issues. Finally, a plan should be put in place to address any identified compliance risks or business issues pre- and post-acquisition.